Dyspnea

There are 7 papers on dyspnea in aging research: 4 trials and 3 observational studies in people. The newest story, Oct 26, 2026: “Higher blood-marker levels linked to worse heart failure outcomes”.

Biomarker

7 papers study it431 more mention it

MeSH

34 new papers in 30 daysSee all 438 papers on dyspnea

  • Human trial4
  • Humans3

Funding

2 grants since 2020

US Department of Veterans AffairsNational Heart, Lung, and Blood Institute$139K

Latest

Dec 2025: 4Jan 2026: 15Feb 2026: 18Mar 2026: 18Apr 2026: 4May 2026: 14Jun 2026: 7Jul 2026: 5Aug 2026: 7Sep 2026: 8Oct 2026: 24Nov 2026: 10134 papers in 12 months
ESC Congress 2026 Abstract

Higher blood-marker levels linked to worse heart failure outcomes

The adjusted hazard ratio, a measure of relative risk, was 1.64 for cardiovascular death or worsening heart failure over two months, comparing highest versus lowest…The adjusted hazard ratio, a measure of relative risk, was 1.64 for cardiovascular death or worsening heart failure over two months, comparing highest versus lowest blood-marker groups.

Randomized trial · 2,400 peopleBiomarkers
AHA Scientific Sessions 2026 Abstract

Drug use linked to better survival in a form of heart failure

At 60 months, survival was 83.5% among users of glucagon-like peptide-1 receptor agonists, versus 57.4% among matched nonusers.At 60 months, survival was 83.5% among users of glucagon-like peptide-1 receptor agonists, versus 57.4% among matched nonusers.

Cohort studyPopulations

See all 438 papers on dyspnea